Document Detail


Intranasal fenoterol in asthmatic subjects: an alternative route of administration.
MedLine Citation:
PMID:  6386936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a double-blind crossover trial the beta 2-agonist fenoterol was administered by the nose and by mouth in 10 patients with stable asthma. In both situations the bronchodilating effect of fenoterol as measured by changes in forced expiratory volume in 1 sec, peak expiratory flow, and maximal expiratory flow at 50% vital capacity was significant (p less than 0.01) compared to placebo. The fenoterol was given in the nose by means of two puffs of 0.2 mg in each nostril (total of 0.8 mg) from a pressurized canister while the patient was holding his breath at total lung capacity; it was followed by an exhalation through the nose. When an effect could be defined as a submaximal plateau, the medication was repeated once. The peroral administration consisted of an inhalation of 0.4 mg of fenoterol from the pressurized canister by use of a standard procedure. Also this medication was repeated after a submaximal effect could be defined. Neither after the first nor the second medication was there any significant difference between the effect on the lung function of the two ways of administration. It is concluded that the intranasal administration of fenoterol can be considered an alternative way of self-administration by the severely ill asthmatic subject who is unable to inhale the bronchodilator or can be used by the emergency staff on the first contact with the severely ill asthmatic patient in the hospital.
Authors:
S Groth; H Dirksen; N Mygind
Related Documents :
6799246 - Respiratory changes after major burn injury.
3763256 - Determinants of the first inspiratory volume and functional residual capacity at birth.
8511736 - Static lung volumes in healthy subjects assessed by helium dilution during occlusion of...
3902386 - Influence of lung and chest wall compliances on transmission of airway pressure to the ...
8325186 - Reduced portosystemic hemodynamic responsiveness after orthostasis in patients with cir...
11098946 - Efficacy of interposed abdominal compression-cardiopulmonary resuscitation (cpr), activ...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of allergy and clinical immunology     Volume:  74     ISSN:  0091-6749     ISO Abbreviation:  J. Allergy Clin. Immunol.     Publication Date:  1984 Oct 
Date Detail:
Created Date:  1984-11-27     Completed Date:  1984-11-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1275002     Medline TA:  J Allergy Clin Immunol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  536-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Adult
Aged
Asthma / drug therapy*
Clinical Trials as Topic
Ethanolamines / administration & dosage*
Female
Fenoterol / administration & dosage*
Humans
Male
Middle Aged
Placebos
Respiratory Function Tests
Respiratory Therapy
Chemical
Reg. No./Substance:
0/Ethanolamines; 0/Placebos; 13392-18-2/Fenoterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Scintigraphic detection of coronary artery thrombi in patients with acute myocardial infarction.
Next Document:  Autoallergic reactions induced by procainamide.